Summary
Date: 10 April 2019
The Therapeutic Goods Administration sought feedback from the RACGP on proposed criteria for Appendix M of the Poisons Standard to support rescheduling of substances from S4 to S3.
The RACGP welcomes this opportunity to re-think the safety and necessity of pharmacy only medication in both S3 and the proposed Appendix M schedule. The RACGP expresses concern that the currently proposed Appendix M poses many risks to our patients and to the healthcare system.